(19)
(11) EP 1 856 148 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.04.2013 Bulletin 2013/15

(45) Mention of the grant of the patent:
13.02.2013 Bulletin 2013/07

(21) Application number: 06708659.5

(22) Date of filing: 07.03.2006
(51) International Patent Classification (IPC): 
C07K 14/575(2006.01)
C07K 16/26(2006.01)
 A61K 38/22(2006.01)
(86) International application number:
PCT/EP2006/060506
(87) International publication number:
WO 2006/094973 (14.09.2006 Gazette 2006/37)

(54)

NEUROPEPTIDES

NEUROPEPTIDE

NEUROPEPTIDES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 07.03.2005 AT 3822005

(43) Date of publication of application:
21.11.2007 Bulletin 2007/47

(73) Proprietor: Kofler, Barbara
5023 Salzburg (AT)

(72) Inventors:
  • MORITZ, Kerstin
    A-5071 Wals Siezenheim (AT)
  • FENNINGER, Katrin
    A-5020 Salzburg (AT)
  • KOFLER, Barbara
    A-5023 Salzburg (AT)

(74) Representative: Sonn & Partner Patentanwälte 
Riemergasse 14
1010 Wien
1010 Wien (AT)


(56) References cited: : 
EP-A- 1 227 152
WO-A-2004/094589
 WO-A-03/074713
   
  • CUNNINGHAM M J ET AL: "Cloning and distribution of galanin-like peptide mRNA in the hypothalamus and pituitary of the macaque" ENDOCRINOLOGY, BALTIMORE, MD, US, vol. 143, no. 3, March 2002 (2002-03), pages 755-763, XP002962195 ISSN: 0013-7227 cited in the application
  • "Abstracts from the Summer Neuropeptide Conference: The 15th Annual Meeting of the Summer Neuropeptide Conference, Miami Beach, Florida, USA, July 5-9, 2005" NEUROPEPTIDES, XX, XX, vol. 40, no. 2, April 2006 (2006-04), pages 137-159, XP005404060 ISSN: 0143-4179
  • "Abstracts 15th European Neuropeptides Club Meeting, Riga, Latvia, 19-21 May 2005" NEUROPEPTIDES, XX, XX, vol. 39, no. 6, December 2005 (2005-12), pages 595-632, XP005177002 ISSN: 0143-4179
  • SANTIC R ET AL: "Differential splicing of the human and murine galanin-like peptide gene" JOURNAL OF NEUROCHEMISTRY, vol. 94, no. Suppl. 2, August 2005 (2005-08), page 184, XP009069264 & 20TH BIENNIAL MEETING OF THE INTERNATIONAL-SOCIETY-FOR-NEUROCHEMISTRY /EUROPEAN-SOCIETY-FOR-NEUROCHEM; INNSBRUCK, AUSTRIA; AUGUST 21 -26, 2005 ISSN: 0022-3042
  • SANTIC R ET AL: "ALARIN IS A VASOACTIVE PEPTIDE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 104, no. 24, 12 June 2007 (2007-06-12), pages 10217-10222,
  • BOUGHTON CK ET AL: "ALARIN STIMULATES FOOD INTAKE AND GONADOTROPHIN RELEASE IN MALE RATS", BRITISH JOURNAL OF PHARMACOLOGY, vol. 161, 2010, pages 601-613,
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).